News
Feb 28 2025
Feb 27 2025
We are officially part of the national CellX infrastructure
Feb 20 2024
Authors: Bilal M El-Masri, Benedeta Leka, Fatima Mustapha, Michael Tveden Gundesen, Maja Hinge, Thomas Lund, Thomas L Andersen, Marta Diaz-delCastillo, Abbas Jafari
Oncotarget. 2024; 15: 20–26.
Published online 2024 Jan 16. doi: 10.18632/oncotarget.28548
About DanSIC
The Danish Spatial Imaging Consortium (DanSIC) is an international research infrastructure dedicated to spatial omics analysis. We were established across Southern Denmark University (Odense) and Aarhus University, Denmark, in the year 2023. We are proudly funded by the Novo Nordisk Foundation.
We aim to facilitate a better understanding and patient-tailored treatment of bone diseases, and other diseases. Our four specialized spatial and molecular imaging platforms and seven overarching state-of-the-art methodologies, bridge the gap between our detailed understanding of individual cell populations and their real-life supracellular context in patients. DanSIC collaborates with scientists from multiple disciplines and take advantage of recent advances in 2D and 3D spatial molecular imaging.
Bridging
Funding
We seek to
Advance understanding in biology with spatial omics
We locate
DEPARTMENT OF FORENSIC RESEARCH
AARHUS UNIVERSITY
DEPARTMENT OF CLINICAL RESEARCH
UNIVERSITY OF SOUTHERN DENMARK
DEPARTMENT OF PATHOLOGY
ODENSE UNIVERSITY HOSPITAL
We bridge
researchers who share a common interest in analyzing cells spatially and tissues at the single-cell level.
DanSIC provides easy access to cutting-edge technologies and robust support for downstream data analysis. The platform’s partnerships extend nationally and internationally.
We enable
the design of patient-relevant translational experiments across all relevant spatial and molecular imaging ranges with our unique and worldwide collaborative network. The combination of interdisciplinary bone experts and state-of-the-art infrastructure will foster major breakthroughs in our understanding of human bone physiology and pathophysiology from tissue level and down to single cell level inpatients.
DanSIC and their national and international partners focus on the skeletal effect of aging, osteoporosis,multiple myeloma, rare genetic disorders, breast and prostate cancer metastasis, type 1 and 2 diabetes and related optimal treatment strategies. DanSIC infrastructure is also open for local DanSIC partners performing non-bone projects, and for research institutions, hospitals, incubators, and larger companies.